PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26024F0422WAKIX 17.8mg TABS — Harmony Biosciences, LLC

Harmony Biosciences, LLC holds $3.2M across 61 federal awards, concentrated at Department of Veterans Affairs (VA). The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jun 30, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)

Awarding office

Harmony Biosciences, LLC

Recipient

Jun 30, 2025

PoP end

$703K

Obligated

$712K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Harmony Biosciences, LLC — $90

Contract facts

Federal

Contract number36C26024F0422

Also listed as36C260-24-F-0422

Also listed as36F79720D0148-36C26024F0422

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentHarmony Biosciences, LLC

CAGE88TU1

UEITD8KAL6BNW67

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79720D0148

Place of performancePITTSBURGH PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 1, 2024

PoP end (current)Jun 30, 2025

Obligated$703K

Current value$712K

Potential value$712K

WAKIX 17.8MG TABS is a federal award for 260-Network Contract Office 20 (36C260) held by Harmony Biosciences, LLC. Estimated value $712K ($703K obligated). Current period of performance ends Jun 30, 2025. Last award drew 1 bidder. Place of performance: PITTSBURGH PA.

Recompete timing

Public

● Past PoP end (417 days ago)

Current PoP ended Jun 30, 2025 (417 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Harmony Biosciences, LLC — $3.2M obligated across 61 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26024F0422?

36C26024F0422 (WAKIX 17.8mg TABS) is a 260-Network Contract Office 20 (36C260) award with a potential value of $712K, currently held by Harmony Biosciences, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-24-F-0422?

36C260-24-F-0422 is the dashed form of PIID 36C26024F0422 (WAKIX 17.8mg TABS), held by Harmony Biosciences, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26024F0422?

260-Network Contract Office 20 (36C260) awarded 36C26024F0422 to Harmony Biosciences, LLC (potential $712K).

Who is the incumbent on 36C26024F0422?

Harmony Biosciences, LLC is the incumbent with $3.2M across 61 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2025.

When does Harmony Biosciences, LLC’s 36C26024F0422 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Aug 5, 2025